AJP - Lung AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 288: L251-L265, 2005. First published October 1, 2004; doi:10.1152/ajplung.00122.2004
1040-0605/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/L251    most recent
00122.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spight, D.
Right arrow Articles by Shanley, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spight, D.
Right arrow Articles by Shanley, T. P.

Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo

Donn Spight, Bin Zhao, Michael Haas, Susan Wert, Alvin Denenberg, and Thomas P. Shanley

Division of Critical Care Medicine, Cincinnati Children’s Hospital Medical Center, and the Cincinnati Children’s Hospital Research Foundation, Cincinnati, Ohio

Submitted 1 April 2004 ; accepted in final form 25 September 2004

Regulation of pulmonary inflammation involves an intricate balance of both pro- and anti-inflammatory mediators. Acute lung injury can result from direct pulmonary insults that activate alveolar macrophages to respond with increased cytokine expression. Such cytokine gene expression is mediated in part via NF-{kappa}B. IL-10 has been previously identified as an important endogenous anti-inflammatory cytokine in vivo on the basis of inhibiting NF-{kappa}B activation; however, the mechanism of this inhibition remains incompletely defined. We hypothesized that IL-10 regulated NF-{kappa}B activation in vivo via I{kappa}K inhibition. A bitransgenic mouse that allowed for externally regulated, lung-specific human IL-10 overexpression was generated. In the bitransgenic mice, introduction of doxycycline induced lung-specific, human IL-10 overexpression. Acute induction of IL-10 resulted in significant decreases in bronchoalveolar lavage fluid neutrophils (48%, P = 0.03) and TNF (62%, P < 0.01) following intratracheal LPS compared with bitransgenic negative mice. In vitro kinase assays showed this decrease to correlate to diminished lung I{kappa}K activity. Furthermore, we also examined the effect of chronic IL-10 overexpression in these transgenic mice. Results show that IL-10 overexpression in lungs of mature mice increased the number of intrapulmonary cells the phenotype of which was skewed toward increased B220+/CD45+ B cells and CD4+ T cells and was associated with increased CC chemokine expression. Thus regulated, lung-specific IL-10 overexpression may have a variety of complex immunologic effects depending on the timing and duration of expression.

interleukin-10; transgenic/knockout; lung; protein kinases; neutrophils; lipopolysaccharide



Address for reprint requests and other correspondence: T. P. Shanley, Div. of Critical Care Medicine, OSB-5, Children’s Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039 (E-mail: tshanley{at}med.umich.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.